Lexicon Pharmaceuticals LXRX
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Lexicon Pharmaceuticals (LXRX) Business Model and Operations Summary
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
Key Insights
Lexicon Pharmaceuticals (LXRX) Core Market Data and Business Metrics
Latest Closing Price
$0.5031Market Cap
$181.87 MillionPrice-Earnings Ratio
-0.80Total Outstanding Shares
361.49 Million SharesTotal Employees
285Dividend
No dividendIPO Date
April 7, 2000SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
2445 Technology Forest Blvd., The Woodlands, TX, 77381
Historical Stock Splits
If you bought 7 shares of LXRX before May 21, 2015, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| May 21, 2015 | 1-for-7 (Reverse Split) |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 15,148,389 Shares | 2.59 | 3/14/2025 | 39,259,612 Shares |
| 4,096,942 Shares | 11.58 | 2/28/2025 | 47,457,048 Shares |
| 2,915,719 Shares | 15.34 | 2/14/2025 | 44,735,672 Shares |
| 5,828,178 Shares | 7.38 | 1/31/2025 | 43,025,344 Shares |
| 5,613,432 Shares | 6.97 | 1/15/2025 | 39,104,772 Shares |
| 4,916,798 Shares | 6.81 | 12/31/2024 | 33,499,569 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $238.35 Million |
| Net Cash Flow | $44.19 Million |
| Net Cash Flow, Continuing | $44.19 Million |
| Net Cash Flow From Operating Activities | $-178.78 Million |
| Net Cash Flow From Financing Activities, Continuing | $238.35 Million |
| Net Cash Flow From Operating Activities, Continuing | $-178.78 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Benefits Costs and Expenses | $228.20 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Income/Loss From Continuing Operations After Tax | $-200.40 Million |
| Operating Income/Loss | $-197.12 Million |
| Research and Development | $84.48 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-200.31 Million |
| Comprehensive Income/Loss | $-200.31 Million |
| Comprehensive Income/Loss Attributable To Parent | $-200.31 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Assets | $298.42 Million |
| Other Non-current Assets | $49.74 Million |
| Fixed Assets | $2.48 Million |
| Other Current Liabilities | $15.73 Million |
| Accounts Payable | $14.80 Million |
| Equity | $145.95 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||